Drosos Karageorgopoulos, MD, PhD, MPH
Drosos Karageorgopoulos, MD, PhD, MPH
Oxford University Hospitals NHS Foundation Trust
Verified email at
Cited by
Cited by
Comparison of SCImago journal rank indicator with journal impact factor
ME Falagas, VD Kouranos, R Arencibia-Jorge, DE Karageorgopoulos
The FASEB journal 22 (8), 2623-2628, 2008
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
DE Karageorgopoulos, ME Falagas
The Lancet infectious diseases 8 (12), 751-762, 2008
Extended-spectrum ‚-lactamase-producing organisms
ME Falagas, DE Karageorgopoulos
Journal of Hospital infection 73 (4), 345-354, 2009
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum ‚-lactamase producing, Enterobacteriaceae infections: a systematic review
ME Falagas, AC Kastoris, AM Kapaskelis, DE Karageorgopoulos
The Lancet infectious diseases 10 (1), 43-50, 2010
‚-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis
DE Karageorgopoulos, EK Vouloumanou, F Ntziora, A Michalopoulos, ...
Clinical Infectious Diseases 52 (6), 750-770, 2011
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections
ME Falagas, GS Tansarli, DE Karageorgopoulos, KZ Vardakas
Emerging infectious diseases 20 (7), 1170, 2014
Etiology of anemia in patients with advanced heart failure
JN Nanas, C Matsouka, D Karageorgopoulos, A Leonti, E Tsolakis, ...
Journal of the American College of Cardiology 48 (12), 2485-2489, 2006
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology
ME Falagas, DE Karageorgopoulos
Clinical infectious diseases 46 (7), 1121-1122, 2008
Late Ebola virus relapse causing meningoencephalitis: a case report
M Jacobs, A Rodger, DJ Bell, S Bhagani, I Cropley, A Filipe, RJ Gifford, ...
The Lancet 388 (10043), 498-503, 2016
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
ME Falagas, PI Rafailidis, E Ioannidou, VG Alexiou, DK Matthaiou, ...
International journal of antimicrobial agents 35 (2), 194-199, 2010
Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis
EK Vouloumanou, E Plessa, DE Karageorgopoulos, E Mantadakis, ...
Intensive care medicine 37, 747-762, 2011
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
DE Karageorgopoulos, R Wang, X Yu, ME Falagas
Journal of Antimicrobial Chemotherapy 67 (2), 255-268, 2012
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
DE Karageorgopoulos, T Kelesidis, I Kelesidis, ME Falagas
Journal of Antimicrobial Chemotherapy 62 (1), 45-55, 2008
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
T Kelesidis, DE Karageorgopoulos, I Kelesidis, ME Falagas
Journal of antimicrobial chemotherapy 62 (5), 895-904, 2008
MRSA in Africa: filling the global map of antimicrobial resistance
ME Falagas, DE Karageorgopoulos, J Leptidis, IP Korbila
PloS one 8 (7), e68024, 2013
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies
ME Falagas, AC Kastoris, DE Karageorgopoulos, PI Rafailidis
International journal of antimicrobial agents 34 (2), 111-120, 2009
Accuracy of ‚-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis
DE Karageorgopoulos, JM Qu, IP Korbila, YG Zhu, VA Vasileiou, ...
Clinical Microbiology and Infection 19 (1), 39-49, 2013
Short-versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis
G Dimopoulos, DK Matthaiou, DE Karageorgopoulos, AP Grammatikos, ...
Drugs 68, 1841-1854, 2008
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
ME Falagas, S Maraki, DE Karageorgopoulos, AC Kastoris, ...
International journal of antimicrobial agents 35 (3), 240-243, 2010
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa†…
G Samonis, S Maraki, DE Karageorgopoulos, EK Vouloumanou, ...
European journal of clinical microbiology & infectious diseases 31, 695-701, 2012
The system can't perform the operation now. Try again later.
Articles 1–20